Medivir AB (publ)
MVRBF · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | $0 | $0 | $0 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$8,526 | -$5,200 | $5,400 | -$7,300 |
| Other Non-Cash | -$16,194 | -$14,500 | -$23,000 | -$32,600 |
| Operating Cash Flow | -$24,720 | -$19,700 | -$17,600 | -$39,900 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$400 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $18 | -$400 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $404 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$135 | -$500 | -$500 | -$500 |
| Financing Cash Flow | -$135 | -$500 | -$500 | -$500 |
| Forex Effect | $3 | $0 | $0 | $0 |
| Net Chg. in Cash | -$24,766 | -$20,600 | -$18,000 | -$40,400 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $142,200 | $162,800 | $180,800 | $221,200 |
| End Cash | $117,434 | $142,200 | $162,800 | $180,800 |
| Free Cash Flow | -$24,720 | -$20,100 | -$17,600 | -$39,900 |